UBS Asset Management Americas Inc. raised its position in Masimo Co. (NASDAQ:MASI) by 11.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 63,588 shares of the medical equipment provider’s stock after purchasing an additional 6,711 shares during the quarter. UBS Asset Management Americas Inc. owned 0.12% of Masimo worth $5,392,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. Bank of New York Mellon Corp raised its position in Masimo by 6.4% in the third quarter. Bank of New York Mellon Corp now owns 1,074,648 shares of the medical equipment provider’s stock valued at $93,021,000 after purchasing an additional 64,882 shares during the period. Old Mutual Global Investors UK Ltd. raised its position in Masimo by 9.0% in the fourth quarter. Old Mutual Global Investors UK Ltd. now owns 881,000 shares of the medical equipment provider’s stock valued at $74,708,000 after purchasing an additional 72,512 shares during the period. JPMorgan Chase & Co. raised its position in Masimo by 6.0% in the third quarter. JPMorgan Chase & Co. now owns 851,234 shares of the medical equipment provider’s stock valued at $72,278,000 after purchasing an additional 48,536 shares during the period. Prudential Financial Inc. raised its position in Masimo by 23.9% in the third quarter. Prudential Financial Inc. now owns 685,268 shares of the medical equipment provider’s stock valued at $59,317,000 after purchasing an additional 132,053 shares during the period. Finally, American Century Companies Inc. raised its position in Masimo by 23.1% in the fourth quarter. American Century Companies Inc. now owns 587,070 shares of the medical equipment provider’s stock valued at $49,784,000 after purchasing an additional 110,107 shares during the period. 82.84% of the stock is currently owned by institutional investors.
Masimo Co. (NASDAQ MASI) opened at $88.35 on Monday. The company has a market cap of $4,562.07, a price-to-earnings ratio of 37.44, a price-to-earnings-growth ratio of 2.32 and a beta of 0.92. Masimo Co. has a 12 month low of $80.69 and a 12 month high of $104.71.
A number of analysts have issued reports on MASI shares. Zacks Investment Research lowered Masimo from a “buy” rating to a “hold” rating in a research report on Wednesday, February 7th. Barclays started coverage on Masimo in a research report on Friday. They issued an “overweight” rating and a $97.00 target price on the stock. BidaskClub lowered Masimo from a “hold” rating to a “sell” rating in a research report on Thursday, December 7th. Finally, Piper Jaffray Companies reissued a “hold” rating and issued a $91.00 target price on shares of Masimo in a research report on Thursday, March 1st. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the company. The company has an average rating of “Buy” and an average price target of $101.00.
In related news, EVP Yongsam Lee sold 10,000 shares of the business’s stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $92.95, for a total transaction of $929,500.00. Following the completion of the transaction, the executive vice president now owns 79,000 shares in the company, valued at $7,343,050. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Sanford Fitch sold 2,000 shares of the business’s stock in a transaction on Thursday, January 25th. The stock was sold at an average price of $90.00, for a total transaction of $180,000.00. Following the transaction, the director now owns 70,249 shares of the company’s stock, valued at approximately $6,322,410. The disclosure for this sale can be found here. In the last 90 days, insiders sold 24,000 shares of company stock valued at $2,177,340. Insiders own 13.10% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This piece was first posted by American Banking News and is the property of of American Banking News. If you are accessing this piece on another website, it was illegally stolen and republished in violation of international trademark & copyright laws. The legal version of this piece can be viewed at https://www.americanbankingnews.com/2018/03/12/masimo-co-masi-shares-bought-by-ubs-asset-management-americas-inc.html.
Masimo Company Profile
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASI).
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.